Adrian Gillissen

4.1k total citations
179 papers, 2.7k citations indexed

About

Adrian Gillissen is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Adrian Gillissen has authored 179 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pulmonary and Respiratory Medicine, 65 papers in Physiology and 29 papers in Epidemiology. Recurrent topics in Adrian Gillissen's work include Asthma and respiratory diseases (57 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (54 papers) and Respiratory and Cough-Related Research (43 papers). Adrian Gillissen is often cited by papers focused on Asthma and respiratory diseases (57 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (54 papers) and Respiratory and Cough-Related Research (43 papers). Adrian Gillissen collaborates with scholars based in Germany, United States and Netherlands. Adrian Gillissen's co-authors include H. Vetter, Uwe R. Juergens, G. Schultze‐Werninghaus, Uwe Dethlefsen, Rudolf Repges, Gratiana Steinkamp, Kurt Racké, Meinolf Stöber, Christian Geßner and Hubert Wirtz and has published in prestigious journals such as Journal of Applied Physiology, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Adrian Gillissen

154 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian Gillissen Germany 27 1.3k 823 445 312 229 179 2.7k
Shakti D. Shukla Australia 27 943 0.7× 443 0.5× 1.1k 2.5× 124 0.4× 300 1.3× 61 2.6k
Paul Kirkham United Kingdom 34 1.4k 1.1× 1.1k 1.3× 1.8k 4.0× 105 0.3× 306 1.3× 66 5.1k
Satoshi Ishizuka Japan 25 309 0.2× 638 0.8× 1.2k 2.7× 218 0.7× 96 0.4× 93 2.8k
Ross N. Butler Australia 38 1.0k 0.8× 609 0.7× 1.1k 2.5× 474 1.5× 38 0.2× 139 4.0k
Ralph Brattsand Sweden 31 1.0k 0.8× 1.1k 1.4× 335 0.8× 45 0.1× 89 0.4× 84 2.8k
Marcellus Henrique Loiola Ponte de Souza Brazil 37 665 0.5× 414 0.5× 938 2.1× 317 1.0× 28 0.1× 157 3.6k
Valeria Raia Italy 40 2.6k 2.0× 400 0.5× 1.2k 2.6× 164 0.5× 171 0.7× 148 5.3k
Juan Fu China 25 665 0.5× 768 0.9× 341 0.8× 34 0.1× 124 0.5× 106 2.0k
Bettina Schock United Kingdom 27 588 0.5× 506 0.6× 663 1.5× 34 0.1× 126 0.6× 66 2.2k
Hannu Kankaanranta Finland 45 2.4k 1.9× 3.2k 3.9× 1.5k 3.3× 172 0.6× 197 0.9× 239 6.7k

Countries citing papers authored by Adrian Gillissen

Since Specialization
Citations

This map shows the geographic impact of Adrian Gillissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Gillissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Gillissen more than expected).

Fields of papers citing papers by Adrian Gillissen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Gillissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Gillissen. The network helps show where Adrian Gillissen may publish in the future.

Co-authorship network of co-authors of Adrian Gillissen

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Gillissen. A scholar is included among the top collaborators of Adrian Gillissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Gillissen. Adrian Gillissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gillissen, Adrian, et al.. (2023). Adjuvante Therapie des nicht-kleinzelligen Lungenkarzinoms. 15(1). 27–31.
2.
Gillissen, Adrian. (2023). Nasale High-flow-Sauerstofftherapie bei COPD mit Hyperkapnie. 20(1). 52–55. 1 indexed citations
3.
Gillissen, Adrian, Christian Geßner, Felix Herth, et al.. (2018). Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial. Respiration. 97(4). 292–301. 6 indexed citations
4.
Gillissen, Adrian. (2014). Novel drugs for COPD treatment. MMW - Fortschritte der Medizin. 156(14). 68. 2 indexed citations
5.
Gillissen, Adrian, et al.. (2009). Biomarker bei infektiösen und nicht infektiösen Lungenerkrankungen außer Malignome. Pneumologie. 63(8). 439–450.
6.
Pabst, Stefan, Adrian Gillissen, Martina Lennarz, et al.. (2009). ADAM33 gene polymorphisms in chronic obstructive pulmonary disease. European journal of medical research. 14(S4). 182–6. 10 indexed citations
7.
Sack, Ulrich, et al.. (2008). Tracheobronchopathia osteochondroplastica: A rare cause of chronic cough with haemoptysis. PubMed. 4(1). 4–4. 18 indexed citations
8.
Hammerschmidt, Stefan, Tobias Vogel, Christian Geßner, et al.. (2007). Protein kinase C inhibition attenuates hypochlorite-induced acute lung injury. Respiratory Medicine. 101(6). 1205–1211. 25 indexed citations
9.
Gillissen, Adrian, et al.. (2007). Clinical efficacy of short-term treatment with extra-fine HFA beclomethasone dipropionate in patients with post-infectious persistent cough.. PubMed. 58 Suppl 5(Pt 1). 223–32. 19 indexed citations
10.
Gillissen, Adrian, et al.. (2007). Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.. PubMed. 58 Suppl 5(Pt 1). 233–41. 6 indexed citations
11.
Geßner, Christian, Stefan Hammerschmidt, Hartmut Kühn, et al.. (2007). Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease. Respiratory Medicine. 101(11). 2271–2278. 23 indexed citations
12.
Pabst, Stefan, Martina Lennarz, Georg Baumgarten, et al.. (2006). A stop codon polymorphism of toll-like receptor 5 is associated with a stable course of chronic obstructive lung disease. European Respiratory Review. 15(101). 177–179. 2 indexed citations
13.
Dierkesmann, R, Adrian Gillissen, H. Mitfessel, et al.. (2005). COPD und Psyche - ein Überblick. Pneumologie. 59(11). 819–830. 4 indexed citations
14.
Juergens, Uwe R., Meinolf Stöber, Kurt Racké, et al.. (2005). Differential Effects of Fexofenadine on Arachidonic Acid Metabolism in Cultured Human Monocytes. Pharmacology. 76(1). 40–45. 3 indexed citations
15.
Juergens, Uwe R., et al.. (2004). Comparison of in vitro-activity of commonly used topical glucocorticoids on cytokine- and phospholipase inhibition.. PubMed. 9(8). 383–90. 5 indexed citations
16.
Gillissen, Adrian, Roland Buhl, H Magnussen, et al.. (2001). Feste Kombination von Budesonid und Formoterol zur Therapie des Asthma bronchiale. Pneumologie. 55(3). 159–162. 4 indexed citations
17.
Ewig, Santiago & Adrian Gillissen. (2000). Therapie der nosokomialen Pneumonie. Medizinische Klinik. 95(10). 597–598. 2 indexed citations
18.
Müller, KM, et al.. (1999). Cough, dyspnoea and purulent sputum in a 66-yr-old nonsmoking female. European Respiratory Journal. 13(2). 456–459. 3 indexed citations
19.
Gillissen, Adrian, Małgorzata Jaworska, Maritta Orth, et al.. (1997). Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respiratory Medicine. 91(3). 159–168. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026